3、abd活性因子与肝病相关研究

《3、abd活性因子与肝病相关研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、美源康富A.B.D活性因子与肝病相关研究美源康富ABD活性因子帮助乙肝治疗美源康富ADB活性因子提升乙肝病人肝脏细胞屮的谷胱甘肽浓度，降低多种转氨酶的活性，降低过氧化物含量，提升白介素浓度，提升乙肝病人的肝功能。美源康富ABD活性因子扭转脂肪肝美源康富ADB活性因子降低脂肪性肝炎病人的转氨酶活性，抑制脂肪氧化变性，帮助肝脏代谢脂肪，明显提高忠者肝功能。美源康富ABD活性因子预防肝脏酒精中毒人朵洒精进入肝脏会因子肝脏洒精屮毒，实一个表现是产生人県氧化自由。美源康富ABD活性因子有效提升肝脏细胞内的谷胱甘肽和谷胱甘肽过氧化酶的浓度和活性，快

2、速排出£）中基，将肝赃损伤降到最低，明显提高肝功能，起到解酒解毒的作用。美源康富ABD活性因子排出肝毒，保肝护肝肝脏是人体敁大排毒器官，重金属、致癌物、药物、化学品、酒精等通过各种渠道进入人体的毒素敁后都会汇聚到肝脏，由肝脏代谢。美源康富ABD活性因子能激活肝细胞产中谷胱甘肽的能力，帮助肝细胞迅速屮和排出毒素，肝脏就不会因为堆积过暈毒素而受损。保肝护肝，排毒抗病。1.TreatmentofChronicHepatitisUsingWheyProtein(Non-Heated)A.Watanabe,K.Higuchi,K.Okada，丫.

3、Shimizu,Y.Kondo*andH.Kohri*DepartmentofInternalMedicine,ToyamaMedicalandPharmaceuticalUniversity,Toyama，Japan，and*OtsukaPharmaceuticalFactory，Inc”NutritionResearchInstitute,Tokushima.Japan.PR514Inanopenstudy，theclinicalefficacyofwheyprotein(ABDBioactiveCytokines:cysteine

4、content;7.6-foldthatofcasein)isolatedfromfreshmilkandpurifiedwithoutbeingheatedwasevaluatedbasedonliverfunctiontest,immunologicalparameters,plasmaorlymphocyteGSHconcentrationsandhepatitisvirusmarkersin25patientswithchronichepatitis巳orC.ABDBioactiveCytokines(12gasprotein)

5、food(mousse)wasgiventwiceaday,inthemorningandevening,for12weeks(testperiod).Casein(12gasprotein)food(mousse)wasgivenfor2weekspriortothestartof-supplementwithABDBioactiveCytokinesfood(inductionperiod)andfor4weeksaftertheend(follow-upperiod).TheeffectsofABDBioactiveCytokin

6、esfoodonvariousclinicalparameterswereexaminedat4-weekintervalsfor18weekstoevaluatetheefficacyofABDBioactiveCytokines.Asaresult,serumALTactivitydecreasedin6of8patientswithchronichepatitisB12weeksafterthestartofsupplementwithABDBioactiveCytokinesfood.PlasmaGSHconcentration

7、swereincreasedin5ofthe8patients.Serum•concentrationsoflipidperoxidessignificantlydecreased8weeksafterABDBioactiveCytokinesfood.SerumIL-2levelsbegantoincrease8weeksandremainedhighevenaftersupplementwithABDBioactiveCytokines-foodhadended.Furthermore,NKactivitywassignifican

8、tlyincreased.However，anitemcorrelatingwithreducedserumALTactivitycouldnotbeclarified.In17patientswithch